We found that adjuvanting QIV with AddaVax resulted in a type 2-skewed host response to infection, with hallmark type 2 cytokines IL-4, IL-5, and IL-13 present in the lung homogenates of the aQIV group at 5 days post-infection. This evidence concerns the gene IL13 and infection.